Tilray Inc.
NASDAQ: TLRY
$5.34
-$0.09 (-1.7%)
Closing price September 18, 2020
A recent final ruling from the U.S. Drug Enforcement Administration has cast doubt on the legality of some non-psychoactive products derived from the hemp.
17 days ago
Tilray reported disappointing quarterly results after the market closed on Monday, and many analysts took to the sidelines.
1 month ago
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
3 months ago
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
3 months ago
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
3 months ago
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
3 months ago
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
4 months ago
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
4 months ago
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
4 months ago
It’s too soon to tell what impact COVID-19 will have on legal and medical cannabis companies such as Canada’s Tilray Inc. But analysts will be watching the company’s next earnings report for...
4 months ago
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
4 months ago
While markets have been recovering since mid-March, cannabis stocks as a whole have not kept pace. Tilray shares have performed the best in this time, more than doubling off of their all-time lows.
5 months ago
Thursday's top analyst upgrades and downgrades included Bed Bath & Beyond, Ciena, DocuSign, eHealth, Faceboook, Netflix, PNC Financial Services, Square, Tilray, Twitter and Zoom Video Communications.
5 months ago
Last Updated: 5 months ago
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
5 months ago
Can Aurora Cannabis do anything to avoid the same fate as its peers that are circling the drain? Can anything the company does return it to its former glory?
5 months ago